PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1437836
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1437836
Fairfield Market Research, a leading market analysis firm, has released a comprehensive report on the Rhodiola Rosea Supplements market, revealing staggering growth projections from 2024 to 2031. The report indicates that global sales of Rhodiola Rosea Supplements in 2024 amounted to a robust US$ 18 Billion, with expectations of reaching a remarkable valuation of US$ 35 Billion by the end of the forecast period.
Factors Fueling Industry Expansion
Mental Health Crisis: With mental disorders such as depression and anxiety on the rise globally, the demand for solutions is at an all-time high. According to the World Health Organization (WHO), approximately 264 million adults worldwide suffer from depression, making it the leading cause of disability. This surge in mental health issues is attributed to various factors including genetic predispositions and traumatic life events.
Role of Rhodiola Rosea: Rhodiola Rosea, categorized as an adaptogen, offers promising benefits in alleviating emotional and mental stress. Research indicates its ability to stimulate serotonin and dopamine activity, promoting healthy emotional and neurological functioning. Moreover, Rhodiola Rosea is renowned for enhancing physical endurance and protecting against ailments like high-altitude sickness and liver damage.
Rising Health Consciousness: With an increasing awareness of mental health importance, coupled with a growing trend towards natural supplements, the demand for Rhodiola Rosea Supplements continues to escalate. Consumers seek safe and effective alternatives to conventional medications, fostering market expansion.
Regional Insights
The United States market for Rhodiola Rosea supplements is expected to witness significant growth over the assessment period. Depression, a prevalent mental disorder affecting a substantial portion of the population, has been a driving factor in the increased demand for natural supplements like Rhodiola Rosea. Factors contributing to this demand include heightened feelings of helplessness, economic distress, and the exacerbation of depression following the Covid-19 pandemic. Government initiatives focusing on mental health and a growing preference for natural remedies over conventional medications due to their adverse effects are expected to further boost the market.
Similar to the United States, the United Kingdom market for Rhodiola Rosea supplements is poised for growth. Depression rates have surged, particularly after the Covid-19 pandemic, contributing to a higher demand for natural supplements. Notably, workplace productivity has also been affected, with a significant portion of employees experiencing symptoms of depression. The rise in popularity of Rhodiola Rosea supplements in the UK can be attributed to their perceived ability to manage depression and enhance mental capacity with minimal side effects.
India faces significant challenges regarding mental health, with a large portion of the population affected by depression and anxiety disorders. Financial problems and unemployment are cited as predominant reasons for the high incidence of depression. Additionally, hypertension affects a considerable number of adults, driven by unhealthy lifestyles. The increasing demand for natural supplements like Rhodiola Rosea to address depression and hypertension is expected to drive market growth in India.
Canada also grapples with a high prevalence of hypertension, primarily due to factors such as unhealthy diets, smoking, stress, and obesity. The popularity of natural supplements like Rhodiola Rosea is rising as individuals seek alternatives to conventional medications with adverse side effects. This trend is anticipated to contribute to the expansion of the Rhodiola Rosea supplements market in Canada.
France faces challenges related to depression, with a significant portion of adults affected. The prevalent use of antidepressants and mood regulators, which often come with adverse side effects, has led to a growing interest in natural supplements like Rhodiola Rosea. This trend towards natural remedies is expected to drive market growth in France during the assessment period.
Category-wise Insights
Form Preference: Rhodiola Rosea Supplements in powder form emerge as a frontrunner, witnessing significant growth due to ease of consumption and absorption, along with cost-effectiveness.
Distribution Channels: Retail sales channel, encompassing pharmacies and retail shops, is poised for prominent growth. Consumers prefer the convenience and accessibility of retail stores, facilitating informed purchase decisions.
Competitive Analysis
Key players in the Rhodiola Rosea Supplements market, including NutraChamps, Now Foods, and Nature's Way, are investing in expanding production capacity and research to meet growing demand and enhance product formulations.
Key Companies Covered